Portadoras de mutaciones en BRCA1 y 2 en familias de alto riesgo del área de Ciudad Real (España): prevalencia mutacional y características clínico-patológicas del cáncer de mama y ovario

Manzanares Campillo, Maria del Carmen; Muñoz Atienza, Virginia; Sánchez Tapia, Eva Maria; Martín Fernández, Jesús.
Rev. senol. patol. mamar. (Ed. impr.) ; 31(2): 59-66, abr.-jun. 2018. tab
Artículo en Español | IBECS (España) | ID: ibc-176782

Documentos relacionados

  1. Impact of germline mutations in cancer-predisposing genes on long-term survival in patients with epithelial ovarian cancer.
  2. The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit.
  3. Ovarian cancer mutational processes drive site-specific immune evasion.
  4. Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma.
  5. Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis.
  6. Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer.
  7. Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.
  8. Practical implementation of frailty models in Mendelian risk prediction.
  9. Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.
  10. [Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].